Thursday – Clinical Track 3B

Name Badge ID(Required)

Full Name(Required)

Enter your first and last names as you would like them to appear on your certificates.

First Last

Email(Required)

Enter the email you used to register for TOXINS 2022.

Please evaluate the speakers

Overall Evaluation

	Excellent	Good	Fair	Poor
How Do We Optimize Outcomes in Pediatric Patients? BoNT Selection, Guidance Methods, Sedation vs No Sedation (Katharine Alter)
To Treat or Not to Treat the Pediatric Patient With BoNT: Are There Long-Term Consequences? (Mark Gormley)
Spasticity-Related Pain in Children/Adolescents With Cerebral Palsy (Florian Heinen)

Presentation free of commercial bias?

	Yes	No
How Do We Optimize Outcomes in Pediatric Patients? BoNT Selection, Guidance Methods, Sedation vs No Sedation (Katharine Alter)
To Treat or Not to Treat the Pediatric Patient With BoNT: Are There Long-Term Consequences? (Mark Gormley)
Spasticity-Related Pain in Children/Adolescents With Cerebral Palsy (Florian Heinen)

If you answered “No, this presentation was not free of commercial bias”, on any of the above, please explain your reason(s).

Applicable to my practice/research

	Yes	No
How Do We Optimize Outcomes in Pediatric Patients? BoNT Selection, Guidance Methods, Sedation vs No Sedation (Katharine Alter)
To Treat or Not to Treat the Pediatric Patient With BoNT: Are There Long-Term Consequences? (Mark Gormley)
Spasticity-Related Pain in Children/Adolescents With Cerebral Palsy (Florian Heinen)

This activity should improve my

	Strongly disagree	Disagree	Neutral	Agree	Strongly agree
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Understanding of the clinical utility of botulinum neurotoxins
Understanding of potential new therapeutic applications of botulinum neurotoxins
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care

Comments